Spectrum Pharmaceuticals is a biopharmaceutical company focused on acquiring, developing, and commercializing novel and targeted oncology therapies. Spectrum has a strong track record of successfully executing across the biopharmaceutical business model, from in-licensing and acquiring differentiated drugs, clinically developing novel assets, successfully gaining regulatory approvals and commercializing in a competitive healthcare marketplace. Spectrum has a late-stage pipeline with novel assets that serve areas of unmet need. This pipeline has the potential to transform the company in the near future. Show more

Location: | Website: www.sppirx.com | Industry: Pharmaceutical Preparation Manufacturing | Sector: Manufacturing


Market Cap

0.00

52 Wk Range

$N/A - $N/A

Previous Close

$1.03

Open

$1.03

Volume

N/A

Day Range

$1.03 - $1.03

Enterprise Value

0.00

Cash

0.00

Avg Qtr Burn

N/A

Insider Ownership

9.68%

Institutional Own.

22.70%

Qtr Updated

09/30/24